Global and United States Urology Drugs Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Urology Drugs Product Introduction
1.2 Market Segments
1.3 Key Urology Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Urology Drugs Market Size Growth Rate by Type
1.4.2 ? (alpha)-blockers
1.4.3 5 a-reductase inhibitors
1.5 Market by Application
1.5.1 Global Urology Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Urology Drugs Market Size, Estimates and Forecasts
2.1.1 Global Urology Drugs Revenue 2015-2026
2.1.2 Global Urology Drugs Sales 2015-2026
2.2 Global Urology Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Urology Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Urology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Urology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Urology Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Urology Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Urology Drugs Revenue Forecast by Region (2021-2026)
3 Global Urology Drugs Competitor Landscape by Players
3.1 Global Top Urology Drugs Sales by Manufacturers
3.1.1 Global Urology Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Urology Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Urology Drugs Manufacturers by Revenue
3.2.1 Global Urology Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Urology Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Urology Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Urology Drugs Revenue in 2019
3.2.5 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Urology Drugs Price by Manufacturers
3.4 Global Urology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Urology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Urology Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Urology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Urology Drugs Market Size by Type (2015-2020)
4.1.1 Global Urology Drugs Sales by Type (2015-2020)
4.1.2 Global Urology Drugs Revenue by Type (2015-2020)
4.1.3 Urology Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Urology Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Urology Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Urology Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Urology Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Urology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Urology Drugs Market Size by Application (2015-2020)
5.1.1 Global Urology Drugs Sales by Application (2015-2020)
5.1.2 Global Urology Drugs Revenue by Application (2015-2020)
5.1.3 Urology Drugs Price by Application (2015-2020)
5.2 Urology Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Urology Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Urology Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Urology Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Urology Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Urology Drugs Sales YoY Growth 2015-2026
6.1.2 United States Urology Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Urology Drugs Market Share in Global Market 2015-2026
6.2 United States Urology Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Urology Drugs Players by Sales (2015-2020)
6.2.2 United States Top Urology Drugs Players by Revenue (2015-2020)
6.3 United States Urology Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Urology Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Urology Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Urology Drugs Price by Type (2015-2020)
6.4 United States Urology Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Urology Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Urology Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Urology Drugs Price Forecast by Type (2021-2026)
6.5 United States Urology Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Urology Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Urology Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Urology Drugs Price by Application (2015-2020)
6.6 United States Urology Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Urology Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Urology Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Urology Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Urology Drugs Market Size YoY Growth 2015-2026
7.2 North America Urology Drugs Market Facts & Figures by Country
7.2.1 North America Urology Drugs Sales by Country (2015-2020)
7.2.2 North America Urology Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Urology Drugs Market Size YoY Growth 2015-2026
8.2 Europe Urology Drugs Market Facts & Figures by Country
8.2.1 Europe Urology Drugs Sales by Country
8.2.2 Europe Urology Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Urology Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Urology Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Urology Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Urology Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Urology Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Urology Drugs Market Facts & Figures by Country
10.2.1 Latin America Urology Drugs Sales by Country
10.2.2 Latin America Urology Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Urology Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Urology Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Urology Drugs Sales by Country
11.2.2 Middle East and Africa Urology Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Astellas
12.1.1 Astellas Corporation Information
12.1.2 Astellas Description and Business Overview
12.1.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Urology Drugs Products Offered
12.1.5 Astellas Recent Development
12.2 Endo
12.2.1 Endo Corporation Information
12.2.2 Endo Description and Business Overview
12.2.3 Endo Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Endo Urology Drugs Products Offered
12.2.5 Endo Recent Development
12.3 GP Pharm
12.3.1 GP Pharm Corporation Information
12.3.2 GP Pharm Description and Business Overview
12.3.3 GP Pharm Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GP Pharm Urology Drugs Products Offered
12.3.5 GP Pharm Recent Development
12.4 Tolmar
12.4.1 Tolmar Corporation Information
12.4.2 Tolmar Description and Business Overview
12.4.3 Tolmar Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tolmar Urology Drugs Products Offered
12.4.5 Tolmar Recent Development
12.11 Astellas
12.11.1 Astellas Corporation Information
12.11.2 Astellas Description and Business Overview
12.11.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Astellas Urology Drugs Products Offered
12.11.5 Astellas Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Urology Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Urology Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Urology Drugs Market Segments
Table 2. Ranking of Global Top Urology Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Urology Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of ? (alpha)-blockers
Table 5. Major Manufacturers of 5 ?-reductase inhibitors
Table 6. Global Urology Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Urology Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Urology Drugs Sales by Regions 2015-2020 (MT)
Table 9. Global Urology Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Urology Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Urology Drugs Sales Forecast by Region (2021-2026) (MT)
Table 12. Global Urology Drugs Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Urology Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Urology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urology Drugs as of 2019)
Table 16. Urology Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Urology Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Urology Drugs Price (2015-2020) (USD/Kg)
Table 19. Urology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Urology Drugs Product Type
Table 21. Date of International Manufacturers Enter into Urology Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Urology Drugs Sales by Type (2015-2020) (MT)
Table 24. Global Urology Drugs Sales Share by Type (2015-2020)
Table 25. Global Urology Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Urology Drugs Revenue Share by Type (2015-2020)
Table 27. Urology Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 28. Global Urology Drugs Sales Share by Type (2021-2026)
Table 29. Global Urology Drugs Sales by Application (2015-2020) (MT)
Table 30. Global Urology Drugs Sales Share by Application (2015-2020)
Table 31. Global Urology Drugs Sales Share by Application (2021-2026)
Table 32. Global Urology Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Urology Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Urology Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Urology Drugs Sales (MT) of Key Companies (2015-2020)
Table 36. United States Urology Drugs Sales Share by Company (2015-2020)
Table 37. United States Urology Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Urology Drugs Sales (MT) by Type (2015-2020)
Table 39. United States Urology Drugs Sales Share by Type (2015-2020)
Table 40. United States Urology Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Urology Drugs Price (MT) by Type (2015-2020)
Table 42. United States Urology Drugs Sales (MT) by Type (2021-2026)
Table 43. United States Urology Drugs Sales Share by Type (2021-2026)
Table 44. United States Urology Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Urology Drugs Revenue Share by Type (2021-2026)
Table 46. United States Urology Drugs Price (MT) by Type (2021-2026)
Table 47. United States Urology Drugs Sales (MT) by Application (2015-2020)
Table 48. United States Urology Drugs Sales Share by Application (2015-2020)
Table 49. United States Urology Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Urology Drugs Sales (MT) by Application (2021-2026)
Table 51. United States Urology Drugs Sales Share by Application (2021-2026)
Table 52. United States Urology Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Urology Drugs Revenue Share by Application (2021-2026)
Table 54. North America Urology Drugs Sales by Country (2015-2020) (MT)
Table 55. North America Urology Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Urology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Urology Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Urology Drugs Sales by Country (2015-2020) (MT)
Table 59. Europe Urology Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Urology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Urology Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Urology Drugs Sales by Region (2015-2020) (MT)
Table 63. Asia Pacific Urology Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Urology Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Urology Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Urology Drugs Sales by Country (2015-2020) (MT)
Table 67. Latin America Urology Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Urology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Urology Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Urology Drugs Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Urology Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Urology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Urology Drugs Revenue Market Share by Country (2015-2020)
Table 74. Astellas Corporation Information
Table 75. Astellas Description and Business Overview
Table 76. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Astellas Urology Drugs Product
Table 78. Astellas Recent Development
Table 79. Endo Corporation Information
Table 80. Endo Description and Business Overview
Table 81. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Endo Product
Table 83. Endo Recent Development
Table 84. GP Pharm Corporation Information
Table 85. GP Pharm Description and Business Overview
Table 86. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. GP Pharm Product
Table 88. GP Pharm Recent Development
Table 89. Tolmar Corporation Information
Table 90. Tolmar Description and Business Overview
Table 91. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Tolmar Product
Table 93. Tolmar Recent Development
Table 94. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 95. Key Challenges
Table 96. Market Risks
Table 97. Main Points Interviewed from Key Urology Drugs Players
Table 98. Urology Drugs Customers List
Table 99. Urology Drugs Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Urology Drugs Product Picture
Figure 2. Global Urology Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. ? (alpha)-blockers Product Picture
Figure 4. 5 ?-reductase inhibitors Product Picture
Figure 5. Global Urology Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Urology Drugs Report Years Considered
Figure 10. Global Urology Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Urology Drugs Sales 2015-2026 (MT)
Figure 12. Global Urology Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Urology Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Urology Drugs Sales Market Share by Region in 2019
Figure 15. Global Urology Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Urology Drugs Revenue Market Share by Region in 2019
Figure 17. Global Urology Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Urology Drugs Revenue in 2019
Figure 19. Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Urology Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Urology Drugs Sales Market Share by Type in 2019
Figure 22. Global Urology Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Urology Drugs Revenue Market Share by Type in 2019
Figure 24. Global Urology Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Urology Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Urology Drugs Sales Market Share by Application in 2019
Figure 27. Global Urology Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Urology Drugs Revenue Market Share by Application in 2019
Figure 29. United States Urology Drugs Sales Growth Rate 2015-2026 (MT)
Figure 30. United States Urology Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Urology Drugs Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Urology Drugs Players Market Share by Revenue in Urology Drugs in 2019
Figure 33. United States Urology Drugs Revenue Share by Type (2015-2020)
Figure 34. United States Urology Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Urology Drugs Revenue Share by Application (2015-2020)
Figure 36. United States Urology Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Urology Drugs Sales Growth Rate 2015-2020 (MT)
Figure 38. North America Urology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Urology Drugs Sales Market Share by Country in 2019
Figure 40. North America Urology Drugs Revenue Market Share by Country in 2019
Figure 41. U.S. Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 42. U.S. Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 44. Canada Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Urology Drugs Sales Growth Rate 2015-2020 (MT)
Figure 46. Europe Urology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Urology Drugs Sales Market Share by Country in 2019
Figure 48. Europe Urology Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 50. Germany Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 52. France Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 54. U.K. Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 56. Italy Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 58. Russia Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Urology Drugs Sales Growth Rate 2015-2020 (MT)
Figure 60. Asia Pacific Urology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Urology Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Urology Drugs Revenue Market Share by Region in 2019
Figure 63. China Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 64. China Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 66. Japan Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 68. South Korea Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 70. India Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 72. Australia Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 74. Taiwan Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 76. Indonesia Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 78. Thailand Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 80. Malaysia Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 82. Philippines Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 84. Vietnam Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Urology Drugs Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Urology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Urology Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Urology Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Urology Drugs Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Urology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Urology Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Urology Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 102. Saudi Arabia Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Urology Drugs Sales Growth Rate (2015-2020) (MT)
Figure 104. U.A.E Urology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Urology Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed